Proteome Sciences (GB:PRM) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Proteome Sciences has reported a dip in revenues and gross profit in H1 2024 compared to the previous year but anticipates a resurgence in orders following the launch of their new TMTpro 35plex tags. The company is optimistic about returning to growth with increased orders in Q3 and the development of their innovative plexDIA tags, which are entering licensing discussions. Additionally, their U.S. lab has begun delivering projects, and a CEO transition is underway with Dr. Mariola Soehngen stepping down in January 2025.
For further insights into GB:PRM stock, check out TipRanks’ Stock Analysis page.